These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24063599)

  • 1. An exceptional case of full-thickness macular hole closure in a patient with Behçet disease.
    Uçar D; Atalay E; Özyazgan Y; Özkök A; Yıldırım Y
    Ocul Immunol Inflamm; 2014 Feb; 22(1):79-81. PubMed ID: 24063599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescein angiography and visual acuity in active uveitis with Behçet disease.
    Yu HG; Kim MJ; Oh FS
    Ocul Immunol Inflamm; 2009; 17(1):41-6. PubMed ID: 19294573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon Alpha-2a Therapy in Patients with Refractory Behçet Uveitis.
    Hasanreisoglu M; Cubuk MO; Ozdek S; Gurelik G; Aktas Z; Hasanreisoglu B
    Ocul Immunol Inflamm; 2017 Feb; 25(1):71-75. PubMed ID: 26910383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal tears associated with panuveitis and Behçet's disease.
    Akova YA; Yilmaz G; Aydin P
    Ophthalmic Surg Lasers; 1999; 30(9):762-5. PubMed ID: 10574500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular ischaemia in Behçet's disease.
    Yilmaz G; Akova Y; Aydin P
    Eye (Lond); 2000 Oct; 14 Pt 5():717-20. PubMed ID: 11116691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full-Thickness Macular Hole Secondary to High-Power Handheld Blue Laser: Natural History and Management Outcomes.
    Alsulaiman SM; Alrushood AA; Almasaud J; Alkharashi AS; Alzahrani Y; Abboud EB; Nowilaty SR; Arevalo JF; Al-Amry M; Alrashaed S; Ghazi NG;
    Am J Ophthalmol; 2015 Jul; 160(1):107-13.e1. PubMed ID: 25892126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous closure of macular hole.
    Jamil AZ; Aqil A; Khaliq J; Mirza KA
    J Coll Physicians Surg Pak; 2014 May; 24 Suppl 2():S115-6. PubMed ID: 24906260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular manifestations of late-onset behçet disease.
    Citirik M; Berker N; Songur MS; Ozkan SS; Zilelioglu O
    Ophthalmologica; 2011; 225(1):21-6. PubMed ID: 20693818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous closure of a recurrent macular hole following vitrecomy corroborated by optical coherence tomography.
    Shaikh S; Garretson B
    Ophthalmic Surg Lasers Imaging; 2003; 34(2):172-4. PubMed ID: 12665236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
    Park JY; Chung YR; Lee K; Song JH; Lee ES
    Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease.
    Gueudry J; Wechsler B; Terrada C; Gendron G; Cassoux N; Fardeau C; Lehoang P; Piette JC; Bodaghi B
    Am J Ophthalmol; 2008 Dec; 146(6):837-44.e1. PubMed ID: 19027420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A full thickness macular hole as an uncommon complication of Behçet disease].
    Angioi-Duprez K; Maalouf T; Gérin M; George JL
    J Fr Ophtalmol; 2001 Feb; 24(2):172-4. PubMed ID: 11240490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous macular hole closure in bilateral macular holes.
    Win PH; Young TA
    Semin Ophthalmol; 2007; 22(3):167-9. PubMed ID: 17763238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous closure of traumatic macular holes.
    Faghihi H; Ghassemi F; Falavarjani KG; Saeedi Anari G; Safizadeh M; Shahraki K
    Can J Ophthalmol; 2014 Aug; 49(4):395-8. PubMed ID: 25103660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous resolution of traumatic macular hole-related retinal detachment.
    Lai MM; Joshi MM; Trese MT
    Am J Ophthalmol; 2006 Jun; 141(6):1148-51. PubMed ID: 16765695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose interferon alfa-2a therapy in severe uveitis associated with Behçet disease.
    Onal S; Kazokoglu H; Direskeneli H; Yavuz S
    Am J Ophthalmol; 2009 Jun; 147(6):1109-10; author reply 1110. PubMed ID: 19463552
    [No Abstract]   [Full Text] [Related]  

  • 17. Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet's disease by infliximab treatment.
    Takeuchi M; Harimoto K; Taguchi M; Sakurai Y
    BMC Ophthalmol; 2015 Dec; 15():177. PubMed ID: 26653575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous closure of full-thickness macular hole in type 2 idiopathic macular telangiectasia.
    Shukla D; Venkatesh R
    Graefes Arch Clin Exp Ophthalmol; 2012 Nov; 250(11):1711-2. PubMed ID: 21938453
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of interferon alpha-2a therapy in patients with Behcet's disease.
    Yalçindağ FN; Uzun A
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):439-43. PubMed ID: 22455657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a].
    Deuter CM; Kötter I; Günaydin I; Zierhut M; Stübiger N
    Ophthalmologe; 2004 Feb; 101(2):129-34. PubMed ID: 14991308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.